2025 Endocrine Case Management: Meet the Professor Faculty
José O. Alemán, MD, PhD
New York University Langone Health
Natasha M. Appelman-Dijkstra, MD, PhD
Leiden University Medical Center
Danit Ariel, MD, MS
Stanford University School of Medicine
Wiebke Arlt, MD, DSc
Medical Research Council Laboratory of Medical Sciences
Tânia Bachega, MD, PhD
São Paulo University School of Medicine
Shichun Bao, MD, PhD
Vanderbilt University Medical Center
Andrew J. Bauer, MD
Children’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine
Jérôme Bertherat, MD, PhD
Paris Cité University and Cochin Hospital
Eveline Bruinstroop, MD, PhD
Amsterdam UMC
Mirjam Christ-Crain, MD, PhD
University Hospital Basel, University of Basel
Stefano Cianfarani, MD
University of Rome, ‘Bambino Gesù’ Children’s Hospital, and Karolinska Institute
Daniel A. Dumesic, MD
University of California Los Angeles David Geffen School of Medicine
Grigoris Effraimidis, MD, PhD
University of Thessaly and University General Hospital of Larissa
Ghada El-Hajj Fuleihan, MD, MPH
American University of Beirut
Rossella Elisei, MD
University Hospital of Pisa and University of Pisa
Dana Erickson, MD
Mayo College of Medicine
Pouneh K. Fazeli, MD, MPH
University of Pittsburgh Medical Center Presbyterian Hospital
Ian Ganly, MD, MS, PhD
Memorial Sloan Kettering Cancer Center
Andrea Glezer, MD, PhD
University of São Paulo Medical School Hospital
Aidar R. Gosmanov, MD, DMSc
Albany Medical College and Stratton Veterans Affairs Medical Center
Claus H. Gravholt, MD, PhD
Aarhus University Hospital
A. G. (Onno) Holleboom, MD, PhD
Amsterdam UMC
Camilo Jimenez, MD
University of Texas MD Anderson Cancer Center
Emmanuel Jouanneau, MD, PhD
Hospices Civils de Lyon, Claude Bernard University, and Cancer Research Center of Lyon
Randol Kennedy, MD
Duke University School of Medicine
Andrew T. Kraftson, MD
University of Michigan
Rayhan Lal, MD
Stanford University
Angela M. Leung, MD, MSc
University of California Los Angeles David Geffen School of Medicine and Veterans Affairs Greater Los Angeles Healthcare System
Eva S. Liu, MD
Brigham and Women’s Hospital and Harvard Medical School
Marco Medici, MD, PhD, MSc
Erasmus Medical Center
Alyson K. Myers, MD
Montefiore Einstein
Michael W. O’Reilly, MD, PhD
Royal College of Surgeons in Ireland
Maria Papaleontiou, MD
University of Michigan
Melissa Putman, MD
Harvard Medical School and Massachusetts General Hospital
Gerald Raverot, MD, PhD
Claude Bernard University, Cancer Research Center of Lyon, and Hospices Civils de Lyon
Tirissa J. Reid, MD, DABOM
Columbia University Vagelos College of Physicians and Surgeons
Alan D. Rogol, MD, PhD
University of Virginia
Micol S. Rothman, MD
University of Colorado School of Medicine
David Saxon, MD, MSc
University of Colorado School of Medicine and Rocky Mountain Regional Veterans Affairs Medical Center
Ellen W. Seely, MD
Brigham and Women’s Hospital and Mass General Brigham
Afreen Shariff, MD
Duke University School of Medicine and Duke Cancer Institute
Ashley Shoemaker, MD, MSCI
Vanderbilt University Medical Center
Marius N. Stan, MD
Mayo Clinic-Rochester
Michael Stowasser, MBBS, PhD
University of Queensland Frazer Institute and Princess Alexandra Hospital
Lisa R. Tannock, MD
Queen’s University
Sonali Thosani, MD
MD Anderson Cancer Center
Selma Feldman Witchel, MD
University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh
Whitney W. Woodmansee, MD, MA
University of Florida
Annual Meeting Steering Committee (AMSC)
Niki Karavitaki, MSc, PhD – AMSC Chair
University of Birmingham
Barbara Gisella Carranza Leon, MD – Clinical Practice Chair
Vanderbilt University Medical Center
Robin Peeters, MD, PhD – Clinical Science Chair
Erasmus Universiteit
Monica Laronda, PhD – Basic Science Chair
Ann & Robert H. Lurie Children's Hospital of Chicago
Annual Meeting Steering Committee Clinical Peer Reviewers
Ana Paula Abreu Metzger, MD, PhD; Olga Astapova, MD, PhD; Irina Bancos, MD; Laura Boucai, MD; Davide Calebiro, MD; Diane Donegan, MBBCh BAO, MRCPI; David A. Ehrmann, MD; Christa E. Flueck, MD; Oksana Hamidi, DO; Ole-Petter Hamnvik, MBBCh BAO, MMSc, MRCPI; Edward Chiaming Hsiao, MD, PhD; Hebatullah M. Ismail, MD; Suzanne Jan De Beur, MD; Srividya Kidambi, MD; Katja Kiseljak-Vassiliades, DO; Raghavendra Mirmira, PhD, MD; Connie Baum Newman, MD; Gabrielle Page-Wilson, MD; Elizabeth N. Pearce, MD, MSc; Luca Persani, MD, PhD; Julie Refardt, MD, PhD; Yumie Rhee, MD, PhD; Laura Torchen, MD; Elena Tsourdi, MD; W. Edward Visser, MD, PhD; Jun Yang, MBBS, PhD; and Elaine Wei-Yin Yu, MD
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring high-quality content in this educational activity that is balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s Annual Meeting Steering Committee.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
José O. Alemán, MD, PhD Novo Nordisk (consultant)
Wiebke Arlt, MD, DSc Diurnal; Roche Diagnostics, Bayer Inc, Organon Laboratories, Crinetics, Spruce Bioscience, European Society of Endocrinology
Andrew J. Bauer, MD IBSA Pharm, Egetis Pharm (consultant)
Jérôme Bertherat, MD, PhD HRA Pharma, Recordati RD, Novo Nordisk
Eveline Bruinstroop, MD, PhD Aligos, Madrigal
Stefano Cianfarani, MD Novo Nordisk, Sandoz
Daniel A. Dumesic, MD Ferring Pharmaceuticals, Organon Laboratories, Spruce Biosciences Inc, Precede Biosciences Inc, Ferring Research Institute
Dana Erickson, MD Camurus, Crinetics (advisory board)
Pouneh K. Fazeli, MD, MPH Regeneron Pharmaceuticals, Crinetics (research support and consultant); Quest Diagnostics, Corcept, Chiesi (consultant)
Aidar R. Gosmanov, MD, DMSc Eli Lilly & Company (research support paid to institution), BMJ Open Diabetes Research & Care (associate editor)
A. G. (Onno) Holleboom, MD, PhD Merck, Novo Nordisk, Boehringer Ingelheim, Inventiva, Echosens
Camilo Jimenez, MD Merck, Exelixis, Inc (research support)
Randol Kennedy, MD Abbott Diabetes Care, Adaptyx Biosciences, Biolinq, Capillary Biomedical, Deep Valley Labs, Gluroo, Portal Diabetes, Tidepool, ProventionBio, Lilly, Sanofi
Eva S. Liu, MD Inozyme
Marco Medici, MD PhD MSc ACE Pharmaceuticals
Alyson K. Myers, MD Eli Lilly & Company, Travel Support for the ExCEL program
Melissa Putman, MD Anagram Therapeutics, Vertex Pharmaceuticals
Tirissa J. Reid, MD, DABOM UpToDate
Alan D. Rogol, MD, PhD Ascendis Pharma, Tolmar, Lumos Pharma, ALK Pharma, Comprehensive Drug Testing, United States Anti-Doping Agency, World Anti-Doping Agency
Afreen Shariff, MD Merck, Novartis Pharmaceuticals, Citrus Oncology, UpToDate
Ashley Shoemaker, MD, MSCI Soleno Therapeutics, Rhythm Pharmaceuticals
Marius N. Stan, MD Argenx, Genentech Inc, Ethyreal Bio, Lessen Inc, Merida, MingHui, Avilar, Viridian (consultant)
Selma Feldman Witchel, MD Neurocrine Biosciences Inc
The following faculty reported no relevant financial relationships:
Natasha M. Appelman-Dijkstra, MD, PhD; Danit Ariel, MD, MS; Tânia Bachega, MD, PhD; Shichun Bao, MD, PhD; Mirjam Christ-Crain, MD, PhD; Grigoris Effraimidis, MD, PhD; Ghada El-Hajj Fuleihan, MD, MPH; Rossella Elisei, MD; Ian Ganly, MD, MS, PhD; Andrea Glezer, MD, PhD; Claus H. Gravholt, MD, PhD; Emmanuel Jouanneau, MD, PhD; Andrew T. Kraftson, MD; Rayhan Lal, MD; Angela M. Leung, MD, MSc; Michael W. O’Reilly, MD, PhD; Maria Papaleontiou, MD; Gerald Raverot, MD, PhD; Micol S. Rothman, MD; David Saxon, MD, MSc; Ellen W. Seely, MD; Michael Stowasser, MBBS, PhD; Lisa R. Tannock, MD; Sonali Thosani, MD; and Whitney W. Woodmansee, MD, MA.
The following AMSC peer reviewers reported relevant financial relationships:
Irina Bancos, MD Adrenas, HRA Pharma, Corcept, Recordati (advisory board); HRA Pharma, Corcept, Sparrow Pharmaceutics, Recordati (consultant); Elsevier (writer); Recordati, NIH (funding for investigator-initiated award); DynaMed (reviewer)
Barbara Gisella Carranza Leon, MD Novartis, IONIS Pharmaceutical Inc, NIH, FH Foundation, Regenxbio, Inc (coinvestigator); Maintenance of Certification Committee: American Board of Obesity Medicine (member)
Diane Donegan, MB BCh BAO, MRCPI Corcept, Recordati (investigator); Camarus (advisory board)
David A. Ehrmann, MD UpToDate (editor); NIH (grant recipient)
Christa E. Flueck, MD European Society Paediatric Endocrinology (advisory board); Novo Nordisk, Merck, Pfizer, Sandoz, Swiss National Science Foundation, European Society Paediatric Endocrinology (grant recipient); Novo Nordisk, Pfizer, EffRx (consultant); Sandoz (speaker); Hormone Research Paediatrics (editor)
Oksana Hamidi, DO Corcept Therapeutics, Crinetics Pharmaceuticals, Neurocrine Biosciences, Recordati Rare Diseases, Camurus (advisory board); Xeris Pharma (speaker)
Ole-Petter Hamnvik, MB BCh BAO, MMSc, MRCPI New England Journal of Medicine (education editor)
Edward Chiaming Hsiao, MD, PhD International FOP Association, FD/MAS Alliance, International Clinical Council on FOP (advisory board); Endocrine Journal, Journal of Bone and Mineral Research (editor); Clementia Pharmaceuticals/Ipsen Pharmaceuticals, Ultragenyx (research investigator)
Suzanne Jan De Beur, MD American Society of Bone and Mineral Research (past president); XLH Network, Current Osteoporosis Reports, Ultragenyx, Kyowa Kirin, Ascendis (advisory board); Bone Reports (editorial board); Mereo, Kyowa Kirin, Calcilytics (researcher); NIH, FDA (grant reviewer); PCORI (investigator)
Niki Karavitaki, MSc, PhD European Neuroendocrine Association (advisory board); HRA Pharma (editor); Recordati Rare Diseases, HRA Pharma, Pfizer, Ipsen, Conselient Health (speaker)
Srividya Kidambi, MD TOPS Inc (medical editor and director)
Katja Kiseljak-Vassiliades, DO HRA Pharma (advisory board)
Raghavendra Mirmira, PhD, MD Journal of Clinical Endocrinology and Metabolism (editor); Veralox Therapeutics (advisory board); Veralox Therapeutics, HiberCell, Inc (investigator-initiated award)
Connie Baum Newman, MD Food and Drug Association (FDA) for Endocrinologic and Metabolic Diseases (advisory committee and consultant); Federation of Medical Women of Canada (honorarium)
Gabrielle Page-Wilson, MD Strongbridge Biopharma, Recordati Rare Diseases, Inc, Xeris BioPharma (advisory board); Xeris BioPharma (consultant)
Elizabeth N. Pearce, MD, MSc Iodine Global Network (management council); Journal of Clinical Endocrinology and Metabolism, DynaMed-thyroid (editor); National Dairy Council, Merck China Symposium (speaker); American Thyroid Association (Guidelines Task Force); World Health Organization (advisory panel)
Luca Persani, MD, PhD Merck, Egetis, Sandoz (advisory board); Merck (speaker); Journal of Clinical Endocrinology and Metabolism, European Thyroid Association, European Thyroid Journal, Pituitary Society, Pituitary (editor)
Yumie Rhee, MD, PhD American Society of Bone and Mineral Research (ambassador); Korean Endocrine Society, Korean Society of Bone and Mineral Research (committee); JCEM Case Reports (editor)
Laura Torchen, MD Levo therapeutics, IBSA Pharma (investigator)
Elena Tsourdi, MD Amgen, Kyowa Kirin, UCB, Alexion, Ascendis (clinical studies); Amgen, UCB, Ascendis (advisory boards and lectures); UCB, Takeda, Ascendis (educational grants)
W. Edward Visser, MD, PhD Egetis Therapeutics (royalties [institution])
Elaine Wei-Yin Yu, MD Amgen (grant recipient)
The following AMSC members reported no relevant financial relationships:
Ana Paula Abreu Metzger, MD, PhD; Olga Astapova, MD, PhD; Laura Boucai, MD; Davide Calebiro, MD; Hebatullah M. Ismail, MD; Julie Refardt, MD, PhD; and Jun Yang, MBBS, PhD